Estrogen, HER2 and EGFR signaling pathways once turned on in different breast cancer subtypes, activate common downstream signaling pathways such as PI3K-AKT and MAPK/ERK pathways which then mediate the hallmarks of cancer. The gene discussed is AKT1; the disease is breast cancer.